Search

Your search keyword '"Meneveau, Nicolas"' showing total 895 results

Search Constraints

Start Over You searched for: Author "Meneveau, Nicolas" Remove constraint Author: "Meneveau, Nicolas"
895 results on '"Meneveau, Nicolas"'

Search Results

1. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

2. Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention

4. OPTImized coronary interventions eXplaIn the bEst cliNical outcomEs (OPTI-XIENCE) study. Rationale and study design

7. Impact of Post-PCI FFR Stratified by Coronary Artery

9. Optical coherence tomography in coronary atherosclerosis assessment and intervention

11. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

13. Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure

14. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

15. Abstract 13130: Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide, Soluble Suppression of Tumorigenicity 2 and Brain Natriuretic Peptide Levels on Heart Rhythm in Persistent Atrial Fibrillation Treated by Electrical Cardioversion: The Biorhythm 2 Study

16. ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France

21. One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

26. Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection

28. Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis

29. OPTImized coronary interventions eXplaIn the bEst cliNical outcomEs (OPTI-XIENCE) study. Rationale and study design

33. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

35. Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial

38. Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry

40. Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry

41. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial

42. Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: The French multicentre S3AR study

46. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry

47. Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry

49. Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions

Catalog

Books, media, physical & digital resources